Long protocols inconvenient compared to simple GH injections.

Variable results made many athletes lose interest.

Pharmaceutical GH became more accessible and predictable.

Multiple daily injections discouraged long term adherence.

Appetite spikes from GHRP annoyed many users.

Water retention issues turned some athletes away.

Newer peptides overshadowed older GHRP protocols.

Cost versus benefit compared poorly to GH.

Users preferred consistent levels from exogenous growth hormone.

Bloodwork responses differed greatly between individuals using them.

Research chemical quality varied widely between suppliers.

Timing around meals complicated protocol adherence daily.

Many bodybuilders switched to MK-677 instead.

Internet trends shifted focus toward GLP peptides.

Harder to manage compared with modern peptide stacks.